Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models - PubMed (original) (raw)
. 2001 Oct 15;61(20):7456-63.
Affiliations
- PMID: 11606380
Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models
K P Bhat et al. Cancer Res. 2001.
Abstract
Trans-3,4',5-trihydroxystilbene (resveratrol), a phytoalexin present in grapes and grape products such as wine, has been identified as a chemopreventive agent. Recent studies performed with MCF-7 human breast cancer cells have demonstrated superestrogenic effects with resveratrol. In contrast, studies performed using estrogen receptor-transfected cell lines have shown that resveratrol acts as a mixed agonist/antagonist. The major objective of this study was to characterize the estrogen-modulatory effects of resveratrol in a variety of in vitro and in vivo mammary models. Thus, the effect of resveratrol alone and in combination with 17beta-estradiol (E2) was assessed with MCF-7, T47D, LY2, and S30 mammary cancer cell lines. With cells transfected with reporter gene systems, the activation of estrogen response element-luciferase was studied, and using Western blot analysis, the expression of E2-responsive progesterone receptor (PR) and presnelin 2 protein was monitored. Furthermore, the effect of resveratrol on formation of preneoplastic lesions (induced by 7,12-dimethylbenz(a)anthracene) and PR expression (with or without E2) was evaluated with mammary glands of BALB/c mice placed in organ culture. Finally, the effect of p.o. administered resveratrol on N-methyl-N-nitrosourea-induced mammary tumors was studied in female Sprague Dawley rats. As a result, in transient transfection studies with MCF-7 cells, resveratrol showed a weak estrogenic response, but when resveratrol was combined with E2 (1 nM), a clear dose-dependent antagonism was observed. Similar mixed estrogenic/antiestrogenic effects were noted with S30 cells, whereas resveratrol functioned as a pure estrogen antagonist with T47D and LY2 cells. Furthermore, in MCF-7 cells, resveratrol induced PR protein expression, but when resveratrol was combined with E2, expression of PR was suppressed. With T47D cells, resveratrol significantly down-regulated steady-state and E2-induced protein levels of PR. With LY2 and S30 cells, resveratrol down-regulated presnelin 2 protein expression. Using the mouse mammary organ culture model, resveratrol induced PR when administered alone, but expression was suppressed in the presence of E2 (1 nM). Furthermore, resveratrol inhibited the formation of estrogen-dependent preneoplastic ductal lesions induced by 7,12-dimethylbenz(a)anthracene in these mammary glands (IC50 = 3.2 microM) and reduced N-methyl-N-nitrosourea-induced mammary tumorigenesis when administered to female Sprague Dawley rats by gavage. Therefore, in the absence of E2, resveratrol exerts mixed estrogen agonist/antagonist activities in some mammary cancer cell lines, but in the presence of E2, resveratrol functions as an antiestrogen. In rodent models, carcinogen-induced preneoplastic lesions and mammary tumors are inhibited. These data suggest that resveratrol may have beneficial effects if used as a chemopreventive agent for breast cancer.
Similar articles
- 3,3'4,4'-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells.
Ramamoorthy K, Gupta MS, Sun G, McDougal A, Safe SH. Ramamoorthy K, et al. Carcinogenesis. 1999 Jan;20(1):115-23. doi: 10.1093/carcin/20.1.115. Carcinogenesis. 1999. PMID: 9934858 - Mechanisms of hormonal prevention of breast cancer.
Medina D, Sivaraman L, Hilsenbeck SG, Conneely O, Ginger M, Rosen J, Omalle BW. Medina D, et al. Ann N Y Acad Sci. 2001 Dec;952:23-35. doi: 10.1111/j.1749-6632.2001.tb02725.x. Ann N Y Acad Sci. 2001. PMID: 11795441 Review. - Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate.
Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R, Elgavish A. Lamartiniere CA, et al. J Nutr. 2002 Mar;132(3):552S-558S. doi: 10.1093/jn/132.3.552S. J Nutr. 2002. PMID: 11880592 Review.
Cited by
- Resveratrol antagonizes EGFR-dependent Erk1/2 activation in human androgen-independent prostate cancer cells with associated isozyme-selective PKC alpha inhibition.
Stewart JR, O'Brian CA. Stewart JR, et al. Invest New Drugs. 2004 Apr;22(2):107-17. doi: 10.1023/B:DRUG.0000011787.75522.ec. Invest New Drugs. 2004. PMID: 14739659 - Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer: modulation of the phosphoinositide 3-kinase pathway.
Benitez DA, Pozo-Guisado E, Clementi M, Castellón E, Fernandez-Salguero PM. Benitez DA, et al. Br J Cancer. 2007 May 21;96(10):1595-604. doi: 10.1038/sj.bjc.6603755. Epub 2007 May 8. Br J Cancer. 2007. PMID: 17486135 Free PMC article. - Bioactive Compounds: Multi-Targeting Silver Bullets for Preventing and Treating Breast Cancer.
Muniraj N, Siddharth S, Sharma D. Muniraj N, et al. Cancers (Basel). 2019 Oct 15;11(10):1563. doi: 10.3390/cancers11101563. Cancers (Basel). 2019. PMID: 31618928 Free PMC article. Review. - Targeting Breast Cancer Stem Cells Using Naturally Occurring Phytoestrogens.
Nguyen M, Osipo C. Nguyen M, et al. Int J Mol Sci. 2022 Jun 18;23(12):6813. doi: 10.3390/ijms23126813. Int J Mol Sci. 2022. PMID: 35743256 Free PMC article. Review. - Pterostilbene, a natural phenolic compound, synergizes the antineoplastic effects of megestrol acetate in endometrial cancer.
Wen W, Lowe G, Roberts CM, Finlay J, Han ES, Glackin CA, Dellinger TH. Wen W, et al. Sci Rep. 2017 Oct 6;7(1):12754. doi: 10.1038/s41598-017-12922-2. Sci Rep. 2017. PMID: 28986550 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials